Clustering algorithm
A position-specific clustering algorithm has been developed that can outperform current model-based clustering methods and provide a fast and effective solution for peak matching in large label-free LC?MS data sets.
A position-specific clustering algorithm has been developed that can outperform current model-based clustering methods and provide a fast and effective solution for peak matching in large label-free LC–MS data sets.
Clustering provides a widely applicable method for recognizing patterns of similar observations within data. A study published in BMC Bioinformatics1 has presented an algorithm called MEDEA (M-Estimator with DEterministic Annealing) and demonstrated its usefulness when recognizing common peaks across LC–MS data sets for proteomic biomarker discovery.
The algorithm is an M-Estimator based, unsupervised algorithm designed to enforce position-specific constraints on variance during the clustering process. By limiting variation within a cluster according to that cluster’s position, the study reports the algorithm outperforms current model-based clustering methods, resulting in an implementation significantly more efficient, and hence applicable to much larger LC–MS data sets.
1. R. Fruehwirth, D.R. Mani and S. Pyne, BMC Bioinformatics, 12(358) (2011).
The Complexity of Oligonucleotide Separations
January 9th 2025Peter Pellegrinelli, Applications Specialist at Advanced Materials Technology (AMT) explains the complexity of oligonucleotide separations due to the unique chemical properties of these molecules. Issues such as varying length, sequence complexity, and hydrophilic-hydrophobic characteristics make efficient separations difficult. Separation scientists are addressing these challenges by modifying mobile phase compositions, using varying ion-pairing reagents, and exploring alternative separation modes like HILIC and ion-exchange chromatography. Due to these complexities, AMT has introduced the HALO® OLIGO column, which offers high-resolution, fast separations through its innovative Fused-Core® technology and high pH stability. Alongside explaining the new column, Peter looks to the future of these separations and what is next to come.
Metabolomics Analysis of Low Birth-Weight Infants Using UHPLC-MS/MS Following Lipid Emulsion
January 10th 2025A recent study aimed to directly compare the changes in serum metabolites among very low birth-rate (VLBW) infants following the administration of the soybean oil-based lipid emulsion and soybean oil, medium-chain triglycerides, olive oil, and fish oil (SMOF) lipid emulsion using untargeted metabolomics techniques.
Analyzing New Drug Modalities: An ISC 2024 Interview with Kelly Zhang
January 10th 2025At ISC 2024 in Liverpool, United Kingdom, LCGC International interviewed Kelly Zhang of Genentech about her work analyzing new drug modalities, such as mRNA, oligonucleotides, peptides, and cell and gene therapies.
